Evista (Raloxifene): Uses, Dosage, Safety and Interactions

Evista contains raloxifene, a prescription selective estrogen receptor modulator (SERM). It is used to treat and prevent osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in certain postmenopausal women with osteoporosis or elevated breast-cancer risk. It is not a treatment for existing breast cancer, does not eliminate breast-cancer risk, and should not be used as a substitute for recommended screening. Patients with a valid prescription may buy Evista from a properly licensed pharmacy after an individual assessment of bone health, breast-cancer risk, and clot or stroke risk. Evista price varies by pharmacy, pack size, and coverage, but cost must never lead to interrupted treatment or a self-directed replacement.

Raloxifene has a boxed warning for increased risk of venous thromboembolism, including deep-vein thrombosis and pulmonary embolism, and for increased risk of death due to stroke in certain women at risk of major coronary events. Before starting therapy, the clinician should weigh these risks against potential benefits and discuss appropriate calcium, vitamin D, physical activity, fall prevention, and bone-density monitoring.

Indications

Evista is indicated for treatment and prevention of osteoporosis in postmenopausal women and for reduction of invasive breast-cancer risk in specified postmenopausal populations. It is not indicated for premenopausal women, pregnancy, breastfeeding, treatment of hot flashes, cardiovascular-disease prevention, or treatment of established breast cancer. A clinician should determine whether raloxifene, another osteoporosis medicine, or another risk-reduction strategy is most appropriate.

Adults using Evista should continue breast screening and follow-up recommended by their clinician. New breast symptoms, unusual vaginal bleeding, a new lump, bone pain, or a fracture after a minor fall requires medical evaluation. Do not assume that raloxifene replaces mammography, bone-density testing, or other preventive care.

Dosage

Take Evista exactly as prescribed, with or without food. The usual dosage is 60 mg once daily. Calcium and vitamin D may be recommended when dietary intake is inadequate, but their dose should be individualized by a healthcare professional. Do not crush, share, or take more tablets than directed. A missed dose should be taken when remembered unless it is close to the next dose; do not double the dose.

Patients with a valid prescription can buy Evista 60 mg when that exact raloxifene strength and regimen have been selected. Patients may buy Evista only after the pharmacy checks the prescription, medical history, and current medicines. Evista price should be compared only for the same 60 mg product and quantity; do not substitute hormones, breast-cancer medicines, or osteoporosis medicines without prescriber guidance.

Evista should be stopped at least 72 hours before and during prolonged immobilization, such as extended bed rest or recovery from surgery, unless the prescriber gives a different plan. During long travel, move regularly when possible and follow individual clot-prevention advice. Do not decide to stop or restart treatment independently.

Safety Information

Do not take Evista if you have active or past venous thromboembolism, including deep-vein thrombosis, pulmonary embolism, or retinal vein thrombosis. It is contraindicated in pregnancy. Tell the prescriber about a prior stroke or transient ischemic attack, coronary heart disease, smoking, hypertension, atrial fibrillation, heart failure, liver disease, kidney impairment, high triglycerides, unexplained uterine bleeding, breast-cancer history, and all planned surgery or periods of reduced mobility.

Seek emergency medical care for one-sided leg swelling or pain, sudden chest pain, shortness of breath, coughing blood, sudden numbness or weakness, new trouble speaking, severe sudden headache, vision changes, or fainting. These can indicate a blood clot or stroke. Common effects may include hot flashes, leg cramps, flu-like symptoms, joint pain, sweating, or peripheral edema. Contact the clinician for any persistent or troubling effect.

Interactions

Tell the prescriber and pharmacist about every prescription medicine, nonprescription product, vitamin, and herbal supplement. Cholestyramine can reduce raloxifene absorption and should not be used together. Warfarin and other anticoagulants may require closer monitoring. Estrogen-containing products and other hormone therapy require individual clinical review. Raloxifene may also affect the handling of some highly protein-bound medicines.

Patients obtaining Evista should use a pharmacy that checks for interactions and confirms clot-risk precautions. Evista price is secondary to safe dispensing and ongoing monitoring. A valid prescription is required to buy Evista. Do not start, stop, or switch hormone-related or osteoporosis treatment without professional advice.

Medical disclaimer: This content is for informational purposes only and does not replace advice, diagnosis, or treatment from a licensed healthcare professional. It is not a substitute for the approved product information or emergency care. Patients should follow their prescriber’s directions and consult their healthcare professional about personal medical decisions, symptoms, medicines, and treatment changes.